The Use of a Virtual Reality System in the Rehabilitation of Children with Progressive Muscular Dystrophies-Reference-Cited by-同舟云学术

The Use of a Virtual Reality System in the Rehabilitation of Children with Progressive Muscular Dystrophies

Published:2024-05-02 Issue:43 Volume:15 Page:359-376
ISSN:0041-8811
Container-title:Revista de la Universidad del Zulia
language:es
Short-container-title:RDLUZ

Author:

Khrystova Tеtіana¹^ORCID,Pyurko Vladyslav²^ORCID,Pyurko Olga¹^ORCID,Protsenko Andriy¹^ORCID,Osadchenko Tetiana³^ORCID,Oliinyk Mykhailo⁴^ORCID

Affiliation:

1. Bogdan Khmelnytsky Melitopol State Pedagogical University, Ukraine.

2. Bogdan Khmelnytsky Melitopol State Pedagogical University, City Council of Zaporizhia Region, Ukraine.

3. Pavlo Tychyna Uman State Pedagogical University, Ukraine.

4. Zaporizhzhia State Medical and Pharmaceutical University, Ukraine.

Abstract

The research aim is to prove the effectiveness of individual programs of physical therapy and occupational therapy for children with progressive muscular dystrophy (PMD), which include game technologies of virtual reality. The following research methods were used in the work: general scientific (analysis, synthesis, synthesis of literature); clinical (clinical examination); pedagogical (observation, experiment); biomedical (development of motor functions), mathematical statistics. It has been proven that after the implementation of a synergistic rehabilitation program on the MFM scale positive changes were observed among children with dystrophic pathologies; according to the Vignos scale, no improvement in results was recorded; according to the Brooke scale - similar situation,among children with PMD Landusy-Dejerin, Emery-Dreyfus and unspecified form, the final results did not differ from the weekend, and among children with Duchenne muscular dystrophy, born PMD and Erb-Roth PMD showed deterioration of parameters.

Publisher

Universidad del Zulia

Reference34 articles.

1. Bérard C., Payan C., Hodgkinson I., Fermanian J., MFM Collaborative Study Group (2005). A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord. 15(7). 463-470. DOI: 10.1016/j.nmd.2005.03.004

2. Bohil C. J., Alicea B., Biocca F. A. (2011). Virtual reality in neuroscience research and therapy. Nat Rev Neurosci. 12 (12). 752-762. DOI: 10.1038/nrn3122

3. Bothwell J. E., Gordon K. E., Dooley J. M., MacSween J., Cummings E. A., Salisbury S. (2003). A clinical approach to muscle diseases. Clin Pediatr. 42(4). 353-356. DOI: 10.1177/000992280304200408

4. Brooke M. H. et al. (1989). Duchenne muscular dystrophy: patterns of clinical progression and eﬀects of supportive therapy. Neurology. 39(4). 475-481. DOI: 10.1212/wnl.39.4.475

5. Bushby K. et al. (2010). Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 9(1) 77-93. DOI: 10.1016/S1474-4422(09)70271-6